According to the TCGA publication that analysed all the stages of CRC [6], ATM did not appear as a top ranked recurrently mutated gene in either the hypermutated (rank 38) or nonhypermutated (rank 20) cohorts. This evidence concerns the gene ATM and colorectal carcinoma.